Evaluating the effects of zoledronic acid (ZOL) on overall survival (OS) in patients (Pts) with multiple myeloma (MM): Results of the Medical Research Council (MRC) Myeloma IX study. Background: ...
We designed a trial using two sequential cycles of modified high-dose melphalan at 100 mg/m 2 and autologous SCT (mHDM/SCT) in AL amyloidosis (light-chain amyloidosis, AL), AL with myeloma (ALM) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results